Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer

Shahrooz Rashtak, Xiaoyang Ruan, Brooke R. Druliner, Hongfang D Liu, Terry M Therneau, Mohamad Mouchli, Lisa Allyn Boardman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: We studied the role of peripheral neutrophil to lymphocyte ratio (NLR) on survival outcomes in colon and rectal cancer to determine if its inclusion improved prognostication within existing staging systems. Patients and Methods: Disease-free (DFS) and overall survival (OS) hazard ratios (HRs) of pretreatment NLR were calculated for 2536 patients with stage I to III colon or rectal cancer and adjusted for age, positive/total number of nodes, T stage, and grade. The association of NLR with clinicopathologic features and survival was evaluated and compared with the American Joint Committee on cancer (AJCC) TNM staging and Memorial Sloan Kettering Cancer Center (MSKCC) models. Results: High NLR was significantly associated with worse DFS (HR, 1.36; 95% confidence interval [CI], 1.08-1.70; P = .009) and OS (HR, 1.65; 95% CI, 1.29-2.10; P < .0005) in all stages for patients with colon, but not rectal, cancer. High NLR was significantly associated with site-specific worse prognosis, which was stronger in the left versus right colon; an inverse relationship with grade was found. The impact of high NLR on DFS and OS occurred early, with the majority of deaths within 2 years following surgery. Adjusted HRs for 5-year and 2-year outcomes in colon cancer per each additional 2-unit increase in NLR were 1.15 (95% CI, 1.08-1.23) and 1.20 (95% CI, 1.10-1.30), respectively. The addition of NLR enhanced the prognostic utility of TNM (TNM alone vs. TNM + NLR: concordance index, 0.60 vs. 0.68), and MSKCC (MSKCC alone vs. MSKCC + NLR: concordance index, 0.71 vs. 0.73) models for colon cancer patients. Conclusion: NLR is an independent prognostic variable for nonmetastatic colon cancer that enhances existing clinical staging systems.

Original languageEnglish (US)
JournalClinical Colorectal Cancer
DOIs
StateAccepted/In press - Aug 18 2016

Fingerprint

Colonic Neoplasms
Neutrophils
Lymphocytes
Rectal Neoplasms
Survival
Confidence Intervals
Neoplasm Staging
Neoplasms
Colon

Keywords

  • Cancer staging
  • Colon cancer survival outcomes
  • Host immune response
  • Prognostication
  • Risk assessment

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer. / Rashtak, Shahrooz; Ruan, Xiaoyang; Druliner, Brooke R.; Liu, Hongfang D; Therneau, Terry M; Mouchli, Mohamad; Boardman, Lisa Allyn.

In: Clinical Colorectal Cancer, 18.08.2016.

Research output: Contribution to journalArticle

@article{5e32003b09b9453ab05cad540bc0f0dd,
title = "Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer",
abstract = "Background: We studied the role of peripheral neutrophil to lymphocyte ratio (NLR) on survival outcomes in colon and rectal cancer to determine if its inclusion improved prognostication within existing staging systems. Patients and Methods: Disease-free (DFS) and overall survival (OS) hazard ratios (HRs) of pretreatment NLR were calculated for 2536 patients with stage I to III colon or rectal cancer and adjusted for age, positive/total number of nodes, T stage, and grade. The association of NLR with clinicopathologic features and survival was evaluated and compared with the American Joint Committee on cancer (AJCC) TNM staging and Memorial Sloan Kettering Cancer Center (MSKCC) models. Results: High NLR was significantly associated with worse DFS (HR, 1.36; 95{\%} confidence interval [CI], 1.08-1.70; P = .009) and OS (HR, 1.65; 95{\%} CI, 1.29-2.10; P < .0005) in all stages for patients with colon, but not rectal, cancer. High NLR was significantly associated with site-specific worse prognosis, which was stronger in the left versus right colon; an inverse relationship with grade was found. The impact of high NLR on DFS and OS occurred early, with the majority of deaths within 2 years following surgery. Adjusted HRs for 5-year and 2-year outcomes in colon cancer per each additional 2-unit increase in NLR were 1.15 (95{\%} CI, 1.08-1.23) and 1.20 (95{\%} CI, 1.10-1.30), respectively. The addition of NLR enhanced the prognostic utility of TNM (TNM alone vs. TNM + NLR: concordance index, 0.60 vs. 0.68), and MSKCC (MSKCC alone vs. MSKCC + NLR: concordance index, 0.71 vs. 0.73) models for colon cancer patients. Conclusion: NLR is an independent prognostic variable for nonmetastatic colon cancer that enhances existing clinical staging systems.",
keywords = "Cancer staging, Colon cancer survival outcomes, Host immune response, Prognostication, Risk assessment",
author = "Shahrooz Rashtak and Xiaoyang Ruan and Druliner, {Brooke R.} and Liu, {Hongfang D} and Therneau, {Terry M} and Mohamad Mouchli and Boardman, {Lisa Allyn}",
year = "2016",
month = "8",
day = "18",
doi = "10.1016/j.clcc.2017.01.008",
language = "English (US)",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",

}

TY - JOUR

T1 - Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer

AU - Rashtak, Shahrooz

AU - Ruan, Xiaoyang

AU - Druliner, Brooke R.

AU - Liu, Hongfang D

AU - Therneau, Terry M

AU - Mouchli, Mohamad

AU - Boardman, Lisa Allyn

PY - 2016/8/18

Y1 - 2016/8/18

N2 - Background: We studied the role of peripheral neutrophil to lymphocyte ratio (NLR) on survival outcomes in colon and rectal cancer to determine if its inclusion improved prognostication within existing staging systems. Patients and Methods: Disease-free (DFS) and overall survival (OS) hazard ratios (HRs) of pretreatment NLR were calculated for 2536 patients with stage I to III colon or rectal cancer and adjusted for age, positive/total number of nodes, T stage, and grade. The association of NLR with clinicopathologic features and survival was evaluated and compared with the American Joint Committee on cancer (AJCC) TNM staging and Memorial Sloan Kettering Cancer Center (MSKCC) models. Results: High NLR was significantly associated with worse DFS (HR, 1.36; 95% confidence interval [CI], 1.08-1.70; P = .009) and OS (HR, 1.65; 95% CI, 1.29-2.10; P < .0005) in all stages for patients with colon, but not rectal, cancer. High NLR was significantly associated with site-specific worse prognosis, which was stronger in the left versus right colon; an inverse relationship with grade was found. The impact of high NLR on DFS and OS occurred early, with the majority of deaths within 2 years following surgery. Adjusted HRs for 5-year and 2-year outcomes in colon cancer per each additional 2-unit increase in NLR were 1.15 (95% CI, 1.08-1.23) and 1.20 (95% CI, 1.10-1.30), respectively. The addition of NLR enhanced the prognostic utility of TNM (TNM alone vs. TNM + NLR: concordance index, 0.60 vs. 0.68), and MSKCC (MSKCC alone vs. MSKCC + NLR: concordance index, 0.71 vs. 0.73) models for colon cancer patients. Conclusion: NLR is an independent prognostic variable for nonmetastatic colon cancer that enhances existing clinical staging systems.

AB - Background: We studied the role of peripheral neutrophil to lymphocyte ratio (NLR) on survival outcomes in colon and rectal cancer to determine if its inclusion improved prognostication within existing staging systems. Patients and Methods: Disease-free (DFS) and overall survival (OS) hazard ratios (HRs) of pretreatment NLR were calculated for 2536 patients with stage I to III colon or rectal cancer and adjusted for age, positive/total number of nodes, T stage, and grade. The association of NLR with clinicopathologic features and survival was evaluated and compared with the American Joint Committee on cancer (AJCC) TNM staging and Memorial Sloan Kettering Cancer Center (MSKCC) models. Results: High NLR was significantly associated with worse DFS (HR, 1.36; 95% confidence interval [CI], 1.08-1.70; P = .009) and OS (HR, 1.65; 95% CI, 1.29-2.10; P < .0005) in all stages for patients with colon, but not rectal, cancer. High NLR was significantly associated with site-specific worse prognosis, which was stronger in the left versus right colon; an inverse relationship with grade was found. The impact of high NLR on DFS and OS occurred early, with the majority of deaths within 2 years following surgery. Adjusted HRs for 5-year and 2-year outcomes in colon cancer per each additional 2-unit increase in NLR were 1.15 (95% CI, 1.08-1.23) and 1.20 (95% CI, 1.10-1.30), respectively. The addition of NLR enhanced the prognostic utility of TNM (TNM alone vs. TNM + NLR: concordance index, 0.60 vs. 0.68), and MSKCC (MSKCC alone vs. MSKCC + NLR: concordance index, 0.71 vs. 0.73) models for colon cancer patients. Conclusion: NLR is an independent prognostic variable for nonmetastatic colon cancer that enhances existing clinical staging systems.

KW - Cancer staging

KW - Colon cancer survival outcomes

KW - Host immune response

KW - Prognostication

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=85016507110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016507110&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2017.01.008

DO - 10.1016/j.clcc.2017.01.008

M3 - Article

C2 - 28365393

AN - SCOPUS:85016507110

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

ER -